https://www.marketscreener.com/quote/stock/ABSCI-CORPORATION-124982799/news/Absci-Corporation-to-Present-Preclinical-Data-for-ABS-101-A-Potential-Best-In-Class-Anti-TL1A-Antib-45691990/?utm_source=telegram&utm_medium=social&utm_campaign=share